You are viewing an expired study

This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please browse nearby listings below.

Click here to view additional nearby studies or search for clinical trials.

Clinical Trial 6412

Montgomery, AL 36106


Study Summary:

A 52-week treatment, randomized, double blind, placebo controlled, with open label tiotropium, parallel-group study to assess the efficacy, safety and tolerability of NVA237 in patients with Chronic Obstructive Pulmonary Disease (COPD)


Qualified Participants Must:

• Be 40 years of age or older
• Have stable moderate to severe COPD


Qualified Participants May Receive:

Free medications and reimbursement for time and travel.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.